303 related articles for article (PubMed ID: 27028432)
1. Accuracy of Patient and Care Partner Identification of Cognitive Impairments in Parkinson's Disease-Mild Cognitive Impairment.
Copeland JN; Lieberman A; Oravivattanakul S; Tröster AI
Mov Disord; 2016 May; 31(5):693-8. PubMed ID: 27028432
[TBL] [Abstract][Full Text] [Related]
2. An assessment of Movement Disorder Society Task Force diagnostic criteria for mild cognitive impairment in Parkinson's disease.
Uysal-Cantürk P; Hanağası HA; Bilgiç B; Gürvit H; Emre M
Eur J Neurol; 2018 Jan; 25(1):148-153. PubMed ID: 28941002
[TBL] [Abstract][Full Text] [Related]
3. Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease.
Goldman JG; Holden S; Bernard B; Ouyang B; Goetz CG; Stebbins GT
Mov Disord; 2013 Dec; 28(14):1972-9. PubMed ID: 24123267
[TBL] [Abstract][Full Text] [Related]
4. MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI.
Litvan I; Aarsland D; Adler CH; Goldman JG; Kulisevsky J; Mollenhauer B; Rodriguez-Oroz MC; Tröster AI; Weintraub D
Mov Disord; 2011 Aug; 26(10):1814-24. PubMed ID: 21661055
[TBL] [Abstract][Full Text] [Related]
5. Assessing the utility of the Movement Disorder Society Task Force Level 1 diagnostic criteria for mild cognitive impairment in Parkinson's disease.
Szeto JY; Mowszowski L; Gilat M; Walton CC; Naismith SL; Lewis SJ
Parkinsonism Relat Disord; 2015 Jan; 21(1):31-5. PubMed ID: 25465744
[TBL] [Abstract][Full Text] [Related]
6. Risk of Parkinson's disease dementia related to level I MDS PD-MCI.
Hoogland J; Boel JA; de Bie RMA; Schmand BA; Geskus RB; Dalrymple-Alford JC; Marras C; Adler CH; Weintraub D; Junque C; Pedersen KF; Mollenhauer B; Goldman JG; Tröster AI; Burn DJ; Litvan I; Geurtsen GJ;
Mov Disord; 2019 Mar; 34(3):430-435. PubMed ID: 30653248
[TBL] [Abstract][Full Text] [Related]
7. Patient and Clinician Impressions of Cognitive Impairment in Parkinson's Disease.
Ngo AB; Smith KM
J Parkinsons Dis; 2020; 10(4):1695-1698. PubMed ID: 32925096
[TBL] [Abstract][Full Text] [Related]
8. Everyday functioning of people with Parkinson's disease and impairments in executive function: a qualitative investigation.
Kudlicka A; Hindle JV; Spencer LE; Clare L
Disabil Rehabil; 2018 Oct; 40(20):2351-2363. PubMed ID: 28597694
[TBL] [Abstract][Full Text] [Related]
9. Mild Cognitive Impairment in Parkinson's Disease: Impact on Caregiver Outcomes.
Szeto JY; Mowszowski L; Gilat M; Walton CC; Naismith SL; Lewis SJ
J Parkinsons Dis; 2016 May; 6(3):589-96. PubMed ID: 27164044
[TBL] [Abstract][Full Text] [Related]
10. Mild cognitive impairment as a risk factor for Parkinson's disease dementia.
Hoogland J; Boel JA; de Bie RMA; Geskus RB; Schmand BA; Dalrymple-Alford JC; Marras C; Adler CH; Goldman JG; Tröster AI; Burn DJ; Litvan I; Geurtsen GJ;
Mov Disord; 2017 Jul; 32(7):1056-1065. PubMed ID: 28605056
[TBL] [Abstract][Full Text] [Related]
11. Detecting Mild Cognitive Deficits in Parkinson's Disease: Comparison of Neuropsychological Tests.
Hoogland J; van Wanrooij LL; Boel JA; Goldman JG; Stebbins GT; Dalrymple-Alford JC; Marras C; Adler CH; Junque C; Pedersen KF; Mollenhauer B; Zabetian CP; Eslinger PJ; Lewis SJG; Wu RM; Klein M; Rodriguez-Oroz MC; Cammisuli DM; Barone P; Biundo R; de Bie RMA; Schmand BA; Tröster AI; Burn DJ; Litvan I; Filoteo JV; Geurtsen GJ; Weintraub D;
Mov Disord; 2018 Nov; 33(11):1750-1759. PubMed ID: 30216541
[TBL] [Abstract][Full Text] [Related]
12. Subjective cognitive complaints in patients with Parkinson's disease.
Kjeldsen PL; Damholdt MF
Acta Neurol Scand; 2019 Dec; 140(6):375-389. PubMed ID: 31433855
[TBL] [Abstract][Full Text] [Related]
13. Evolution of diagnostic criteria and assessments for Parkinson's disease mild cognitive impairment.
Goldman JG; Holden SK; Litvan I; McKeith I; Stebbins GT; Taylor JP
Mov Disord; 2018 Apr; 33(4):503-510. PubMed ID: 29488270
[TBL] [Abstract][Full Text] [Related]
14. Mild cognitive impairment is linked with faster rate of cortical thinning in patients with Parkinson's disease longitudinally.
Hanganu A; Bedetti C; Degroot C; Mejia-Constain B; Lafontaine AL; Soland V; Chouinard S; Bruneau MA; Mellah S; Belleville S; Monchi O
Brain; 2014 Apr; 137(Pt 4):1120-9. PubMed ID: 24613932
[TBL] [Abstract][Full Text] [Related]
15. Contribution of language studies to the understanding of cognitive impairment and its progression over time in Parkinson's disease.
Auclair-Ouellet N; Lieberman P; Monchi O
Neurosci Biobehav Rev; 2017 Sep; 80():657-672. PubMed ID: 28782623
[TBL] [Abstract][Full Text] [Related]
16. Cognitive impairment in Parkinson's disease: Associations between subjective and objective cognitive decline in a large longitudinal study.
Mills KA; Schneider RB; Saint-Hilaire M; Ross GW; Hauser RA; Lang AE; Halverson MJ; Oakes D; Eberly S; Litvan I; Blindauer K; Aquino C; Simuni T; Marras C
Parkinsonism Relat Disord; 2020 Nov; 80():127-132. PubMed ID: 32987359
[TBL] [Abstract][Full Text] [Related]
17. Cognitive impairment in early-stage non-demented Parkinson's disease patients.
Pfeiffer HC; Løkkegaard A; Zoetmulder M; Friberg L; Werdelin L
Acta Neurol Scand; 2014 May; 129(5):307-18. PubMed ID: 24117192
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers for dementia and mild cognitive impairment in Parkinson's disease.
Delgado-Alvarado M; Gago B; Navalpotro-Gomez I; Jiménez-Urbieta H; Rodriguez-Oroz MC
Mov Disord; 2016 Jun; 31(6):861-81. PubMed ID: 27193487
[TBL] [Abstract][Full Text] [Related]
19. Selection of Normative Group Affects Rates of Mild Cognitive Impairment in Parkinson's Disease.
Wyman-Chick KA; Martin PK; Weintraub D; Sperling SA; Erickson LO; Manning CA; Barrett MJ
Mov Disord; 2018 May; 33(5):839-843. PubMed ID: 29442392
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
